Pidilite's operating performance of the company was healthy, with the quarter’s EBITDA standing at ₹623.5 crore.

The company had reported an EBITDA of ₹1,359 crore during the same period last year. EBITDA margin was at 14.26%, versus ...

Indian pharma giant Cipla released its Q4 FY 25 result, wherein it posted a healthy year-on-year growth of 30% in net profit ...

PANDEMIC? May 2025 marks a full five years since the post-pandemic recovery started and gathered steam. That is a good time ...

Ather posted a net loss of ₹812 crore, a remarkable turn-around from ₹1,059.7 crore in FY24, headed towards profitability.

The floor price of the transaction is fixed at ₹1,025 per share. This represents an 8.3% discount to the company's current ...

With average SIP flows at ₹24,113 Crore in FY25, a logical target would be to average over ₹30,000 Crore of gross SIP flows a ...

The sale of the stake is likely to be done through its affiliate General Atlantic Singapore Fund Pte in around 1.18 crore ...

The Board of Directors proposes a final dividend of ₹3 per equity share, representing 150% of the face value of ₹2 per share ...

The business informed the shareholders that bottomline growth was leveraged by robust other income and lower exceptional ...

The revenue from operations of the company posted a healthy 18.7% YoY growth to ₹197 crore from ₹166 crore in the same ...

Revenue increased 19% quarter on quarter to ₹726 crore in the March quarter from ₹609.6 crore for the previous quarter ...